Search

everythinglearnresearchcommunity

for

Search:↓

The serum with microneedling effectively treats alopecia areata by enhancing drug delivery and is safe and patient-friendly.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Dupilumab may help treat alopecia areata without needing high IgE levels.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Dupilumab can cause unexpected scalp issues, so early symptom recognition is important to avoid hair loss.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.